Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Pontificia Universidad Católica de Chile · Western University · +10 more institutions
Indexed incrossrefdoajpubmed
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the leading causes of chronic liver disease globally. Based on the 2023 definition, MASLD is characterized by the presence of metabolic dysfunction and limited alcohol consumption (
Citation impact
44
total citations
- FWCI
- 46.74
- Percentile
- 100%
- References
- 263
Citations per year
Authors
18- LALuis Antonio DíazCorresponding
Pontificia Universidad Católica de Chile
- JPJuan Pablo Arab
Pontificia Universidad Católica de Chile
- FIFrancisco Idalsoaga
Western University, Pontificia Universidad Católica de Chile
- JPJaviera Perelli
Universidad de Los Andes, Chile, Clínica MEDS (Chile)
- JAJavier Andrés Vega
Pontificia Universidad Católica de Chile
Topics & keywords
Topics
Keywords
- Medicine
- Latin Americans
- Internal medicine
- Gerontology
- Family medicine
No related works found for this paper.